Lisa M. Eubanks, PhD, Staff Scientist at the Scripps Research Institute and the Skaggs Institute for Chemical Biology:

“In contrast to previous studies aimed at utilizing cannabinoids in Alzheimer’s disease therapy, our results provide a mechanism whereby the THC molecule can directly impact Alzheimer’s disease pathology…

It is noteworthy that THC is a considerably more effective inhibitor… than the approved drugs for Alzheimer’s disease treatment, donepezil and tacrine, which reduced [protein deposits in the brain] by only 22% and 7%, respectively, at twice the concentration used in our studies…

THC and its analogues may provide an improved therapeutic for Alzheimer’s disease [by] simultaneously treating both the symptoms and progression of Alzheimer’s disease.”

Aug. 9, 2006 article “A Molecular Link Between the Active Component of Marijuana and Alzheimer’s Disease Pathology,” Molecular Pharmaceutics